FindTrial
Sign In

The effectiveness of prophylactic doses of intravenous nitroglycerin in preventing the incidence of myocardial ischemia under general anesthesia

The effectiveness of prophylactic doses of intravenous nitroglycerin in preventing the incidence of myocardial ischemia under general anesthesia - The effectiveness of prophylactic doses of intravenous nitroglycerin in preventing the incidence of myocardial ischemia under general anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000021467
Enrollment
200
Registered
2016-03-14
Start date
2015-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myocardial ischemia

Interventions

None listed

Sponsors

Saitama medical university hospital, Anesthsiology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: This review included all randomized controlled trials investigating the incidence of MI associated with TNG compared with placebo in surgical patients.

Exclusion criteria

Exclusion criteria: We excluded observational studies and those published as an abstract.

Design outcomes

Primary

MeasureTime frame
incidence of myocardial ischemia—

Countries

Japan

Contacts

Public ContactHiroshi Hoshijima

Saitama medical university hospital Anesthesiology

hhoshi@saitama-med.ac.jp049-276-1271

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026